M&A Activity Picks Up in F&B Sectors, Including Functional

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
247
M&A Activity Picks Up in F&B Sectors, Including Functional Water Assets Space

NetworkNewsWire Editorial Coverage: After a sluggish start to 2020, merger and acquisition activity in the food and beverage industry survived COVID-19 and picked up in H2, with 136 of the year’s 222 transactions closing after June last year. Total transaction value for the year was $13.8 billion, only slightly lower than 2019. Despite the lingering pandemic, consolidation continues in the industry and deal flow has returned to a torrid pace, creating an exceptionally attractive market climate for The Alkaline Water Company Inc. (NASDAQ: WTER)(CSE: WTER) (Profile), the U.S.’s largest independent alkaline water company, and its Alkaline88(R) brand, which is now endorsed by Shaquille O’Neal, NBA Hall of Famer and Papa John’s International (NASDAQ: PZZA) board member. Last years’ action included growth equity investor PowerPlant Ventures buying ZICO coconut water from Coca-Cola Company (NYSE: KO) and Nestle SA (OTC: NSRGY) acquiring Essentia Water for an estimated $1 billion, a strategic move to strengthen its value-added water business to compete with brands like PepsiCo Inc. (NASDAQ: PEP), which bolstered its water portfolio with the acquisition of SodaStream in 2018. Only slightly stunted by the pandemic in 2020, M&A in the food and beverage industry should accelerate as competition among majors intensifies and suitable targets dwindle.

WTER is now the largest independent alkaline water company in the nation, having reported 2020 FY revenue of $41.1 million, representing 28% YoY.
Alkaline water is an emerging market, expected to reach $1 billion in 2022.
On average, each American drank 43.7 gallons of bottled water in 2019, driving sales to $34.6 billion.
WTER partners with NBA legend Shaquille O’Neal, who will serve as advisory board member and brand ambassador.


Water, Water Everywhere

Bottled water is hands down the most popular beverage in America by volume, outselling carbonated soft drinks for the fourth straight year in 2019, according to Beverage Marketing Corporation. Sales in 2019 reached $34.6 billion. Data from market research firm Statista shows that 88% of Americas drink water every day and 26% buy name brand water, with every person in America drinking, on average, 43.7 gallons of bottled water in 2019.

The megatrend the water majors are now trying to capture is the increasing consumer health consciousness towards enhanced water as a replacement for sugary drinks. The trend accelerated with people on lockdown buying enhanced water for a slew of reasons, but the fact remains that many consumers have now incorporated value-added waters as part of their lifestyle.

The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) is the largest independent player in the alkaline water market that is expected to reach $1 billion by next year. As the name implies, the Scottsdale, Arizona-based company specializes in producing drinking water with trace minerals and electrolytes and a higher pH, specifically 8.8, than regular drinking water, which has a neutral pH of 7. The higher pH is believed by advocates to have a bevy of benefits, potentially slowing the aging process, regulating the body’s pH level (neutralizing acidity commonly presented in some diseases) and deactivating pepsin, a principal culprit in acid reflux. Though, The Alkaline Water Company does not make any of these claims.

In addition to its flagship Alkaline88 brand, the company responded to consumer demand by launching a new line of six flavor-infused products branded A88 Infused(TM) in 2019. The products are sold in an estimated 75,000 retail stores, which while impressive, leaves plenty of headroom for growth as it represents only 8% of all retail and hospitality outlets available to consumers. The company is aiming for 90,000–100,000 retail locations in the next year. Any bigger peer looking for immediate market share could leverage WTER’s existing distribution — plus its Direct Store Delivery (“DSD”) platform that now reaches over 10,000 customers — combine it with their network and dominate the alkaline water market segment.

Repeat Customers a Staple

The brand awareness and newfound loyalty during COVID-19 was best exemplified by independent data that showed 31% of the people who drank Alkaline88 during the 52-week period ended March 6, 2021, were first-time buyers. The same research showed that 47% of the people who tried Alkaline88 in the last year have purchased it at least four times.

Part of the reason for the loyalty likely has to do with the social culture of The Alkaline Water Co. Millennials and younger generations are passionate about ethos and factor that into decision making about purchases. The company adheres to the strictest industry guidelines set forth by individual states, FDA, EPA and International Bottled Water Association (“IBWA”). It has retooled its ionization system to use less water and electricity and was the first national company in the industry to offer eco-friendly aluminum packaging options.

Shaq’s Golden Rule for Endorsements

Shaquille O’Neal is known not only for his legendary NBA career and four NBA championship rings but also his business skills that have built his brand’s empire. He’s widely recognized for his prowess as a marketing influencer, a skill attributed to both his massive fan base and his refined business acumen to be selective in what he endorses and to not dilute his value. Today, Shaq stars in commercials for The General, Icy Hot, Papa John’s, Ring and Carnival Cruise Lines among other tier-one brands.

As he said in a 2018 interview with HBO Real Sports, O’Neal won’t promote a product unless he genuinely likes it or uses it himself. “If I am going to sell to the people, I have to be honest to the people,” O’Neal said during the interview.

That says a great deal about WTER as Shaq recently entered a three-year partnership with The Alkaline Water Company. According to the partnership, O’Neal will join the company as an equity partner and member of the board of advisors; he will also serve as a marquee brand ambassador for Alkaline88.

“Alkaline88 is an innovative product in the water category and I am so excited to partner with The Alkaline Water Company to help raise their game to new heights,” said O’Neal. “I am humbled by the opportunity to join the Advisory Board while also being a brand ambassador.”

WTER officials noted that Shaq’s track record as a basketball champion and Hall of Famer has translated into similar successes in business and corporate partnerships. “His reputation as an astute investor, larger-than-life brand partner, and phenomenal ambassador makes this partnership extremely exciting,” said Aaron Keay, Chairman of The Alkaline Water Company. “We want to welcome Shaquille to the company’s advisory board and believe his positive presence and global outreach will enable Alkaline88(R) to aggressively push our growth trajectory even faster.”

Accelerating an Already Steep Growth Curve

With 47% customer retention, the key to Alkaline88 becoming a household brand is a numbers game that can be won quickly with Shaq on the team as well as other partnerships and team members the company is building. For example, just months ago The Alkaline Water Company partnered with Hensley Beverage Company for direct-to-store delivery (“DSD”) throughout the state of Arizona.

In addition, WTER’s last full-year financials included record numbers. Q4 2020 revenue reached $12.1 million, representing year-over-year growth of 51%, while full-year growth for 2020 came in at $41.1 million, which comes in at 28% year-over-year growth. These sales figure are particularly relevant in the food and beverage industry as a quantifiable metric of value. Beverage companies traditionally sell between four to six times gross revenue.

In Q3 fiscal 2021, which ended December 31, 2020, the company reported record revenue of $10.2 million, a 20% increase from the year prior quarter. Even factoring zero growth resulting from WTER’s recent partnership announcements, which seems extremely unlikely, the company’s FY 2021 forecast would be approximately $41 million, holding steady with last year’s performance. Currently, WTER’s market cap is an estimated $105 million, or 2.5x gross revenue. In a market that has seen segment leaders such as Core and Essentia acquired at highly favorable multiples, The Alkaline Water Co. stands out as a potentially undervalued takeover candidate.

Majors Fork Out Billions to Make Billions More

The writing has been on the wall for two decades that consumer trends were headed away from sugary drinks and straight toward more flavorful and functional waters that are perceived as far healthier. Beverage companies have had to adapt, and the majors have shown that they’re not afraid to open their checkbooks in order to carve back some of the evaporating soda revenue via value-added waters.

Coca-Cola Company (NYSE: KO) may be best known for its eponymous brand, but the product lineup runs deep into other beverages, including popular offerings such Powerade, I LOHAS, Bon Aqua and Dasani that generate more than $1 billion each annually for Coke. In 2007, Coke made its then biggest ever acquisition, paying $4.1 billion for Glaceau Vitamin Water, which was doing $350 million in annual sales (11.7x gross revenue). Coke has since grown the brand to over $1 billion in annual sales.

PepsiCo Inc. (NASDAQ: PEP) has been no stranger to the acquisition pathway to diversify from carbonated beverages. In 2018, Pepsi shelled out $3.2 billion in for SodaStream in 2018, a 31% premium to a stock that was already up substantially for the year. During the latest quarter before the deal was announced, SodaStream brought in a record $171.5 million (equating to a 4.7x gross revenue buyout). Last year, at the peak of the pandemic in March, Pepsi agreed to pay $3.85 billion for the popular energy drink maker Rockstar Energy Beverages, a buyout meant to give Pepsi more exposure to rising demand in the functional beverage space.

Nestle SA ADR (OTC: NSRGY) shook up the beverage market this year while ultimately sending a clear message where its expertise sees the best market opportunity. Terms weren’t disclosed, but Nestle announced that it had acquired Essentia. The acquisition news came only weeks after Nestle sold its North American bottled water business, essentially a collection of spring water brands, to private equity firms One Rock Capital Partners and Metropoulos & Co. for $3.2 billion. Nestle believes the sale has it better positioned to capture emerging consumer trends, such as functional water.

Papa John’s International Inc. (NASDAQ: PZZA) makes sure its menu caters to those seeking alternatives to carbonated soda. The company is partnered with both Pepsi and Coke, meaning the restaurant, depending on location serves Aquafina, LIFEWTR, Dasani, Gatorade and Montellier Sparkling Water, made by Canadian Pepsi bottler Alex Coulombe ltée, with Pepsi holding the U.S. contract and Coke serving most international locations.

What’s of particular interest is that the functional water sector has exceptionally few established companies with stand-out products and growing at a strong clip. Those that are checking all the boxes certainly won’t be overlooked when the majors go shopping for their next takeover target.

For more information about The Alkaline Water Company, please visit The Alkaline Water Company.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Alkaline Water Company Inc. (WTER) Stock Research Links

WTER Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading